IMPROVING OUR PATIENTS’
QUALITY OF LIFE

Adacyte Therapeutics is a pioneering company committed to the development and commercialization of unique and innovative therapeutic solutions for the treatment of complex diseases.

Learn more

Our commitment is taking care of your health

Our genuine interest in patients voice inspires our vision to continue globally developing GMA (Granulocyte-Monocyte Apheresis) as an effective and safe treatment option for IBD and other autoimmune diseases. GMA is today a growing and emerging medical technology which offers a therapeutic alternative to the standard treatments.

ANTONI VILLARÓ Founder & CEO
Antoni Villaró

Our WorkTherapeutic Areas

Autoimmune diseases directly affect more than 27 million people in Europe alone

* en

OUR PRODUCTS

Adacolumn
Adacolumn
  • GMA offers a therapeutic effect without the debilitating side effects usually associated with immunosuppressive drugs.

HEALTHCARE PROFESSIONAL AREA

Adacyte Therapeutics is a multinational company committed to the development of unique health technologies aimed at improving patients’ health and its quality of life.

Visit professional site

ADACYTE STORIESLatest News

Contact UsFor more information

Contact Us